Efficacy and Safety of Switching from Adalimumab Originator to SB5 Biosimilar in Noninfectious Uveitis: Early Clinical Outcomes. - Song, Ji Hun; Kim, Chungwoon; Chung, Yoo-Ri; Kim, Hae Rang (Journal of Clinical Medicine, 2025)